FA
DXCM icon

Friess Associates’s DexCom DXCM Stock Holding History

Friess Associates’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-137,644
Closed -$2.92M – 115
2017
Q1 		$2.92M Buy
+137,644
New +$2.69M 0.27% 79
2015
Q1 		– Sell
-240,000
Closed -$3.3M – 154
2014
Q4 		$3.3M Buy
+240,000
New +$2.94M 0.27% 81
2014
Q3 		– Sell
-1,517,472
Closed -$15M – 147
2014
Q2 		$15M Buy
+1,517,472
New +$13.4M 1.23% 40

Other funds holding DXCM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Friess Associates's DXCM Position: Q2 2017 in Review

Friess Associates sold out of DexCom (DXCM) in Q2 2017, closing a stake of 137,644 shares — an estimated $2.92M sold.

Friess Associates first reported a position in DXCM in Q2 2014 and held it in 3 quarters. The position peaked at $15M in Q2 2014. 310 funds tracked by Wall St. Rank hold DXCM as of Q2 2017.

  • Friess Associates reported no remaining DexCom position as of Q2 2017 after selling out during the quarter.
  • Friess Associates sold 137,644 DexCom shares in Q2 2017, an estimated $2.92M.
  • Friess Associates first reported a position in DexCom in Q2 2014 and held it in 3 quarters.
  • Friess Associates's DexCom position peaked at $15M in Q2 2014.
  • 310 funds tracked by Wall St. Rank held DexCom as of Q2 2017.

Based on Friess Associates's 13F filing for Q2 2017, filed 14 Aug 2017.